HAO BAI INTL (08431): Zhang Jiaqing appointed as executive director
Hao Bo International (08431) announced that Mr. Zhang Jiaqing has been appointed as an executive director of the company, effective from February 16, 2026.
HAO BAI INTL (08431) announced that Mr. Zhang Jiaqing has been appointed as an executive director of the company, effective from February 16, 2026.
Mr. Liu Mingqing has resigned as an executive director and chairman of the board of directors of the company, effective from February 16, 2026, in order to focus more on his personal career.
Mr. Jiang Bin has resigned as an executive director of the company, effective from February 16, 2026, in order to focus more on other business interests.
Mr. Wang Minghui has been appointed as an independent non-executive director of the company, as well as a member of the audit committee, remuneration committee, and nomination committee, effective from February 16, 2026.
Related Articles

HAO BAI INTL (08431) terminates proposed joint venture agreement

Xinming China (02699) plans to conduct a rights issue based on a "1 for 6" ratio, with a net fundraising amount of approximately HK$101 million.

DINGDANG HEALTH(09886): Meng Fanzhou appointed as Executive Director and Vice President.
HAO BAI INTL (08431) terminates proposed joint venture agreement

Xinming China (02699) plans to conduct a rights issue based on a "1 for 6" ratio, with a net fundraising amount of approximately HK$101 million.

DINGDANG HEALTH(09886): Meng Fanzhou appointed as Executive Director and Vice President.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


